| Melinda Hart, MD | |
|
1890 Al Highway 157, Suite 300, Cullman, AL 35058-3601 | |
| (256) 737-8000 | |
| (256) 737-8058 |
| Full Name | Melinda Hart |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 1890 Al Highway 157, Cullman, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174528020 | NPI | - | NPPES |
| 051553847 | Medicaid | AL | |
| 51553847 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25162 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cullman Regional Medical Center | Cullman, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cullman Internal Medicine, Pc | 2365354339 | 24 |
News Archive
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth of liver tissue in patients who have had parts of their liver removed surgically.
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments today announced it has received FDA 510(k) clearance of its new Clear + Brilliant laser aesthetic treatment, which will officially launch at the World Congress of Dermatology in Seoul, Korea on May 25, 2011.
› Verified 3 days ago
| Entity Name | Cullman Regional Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114919339 PECOS PAC ID: 3274445242 Enrollment ID: O20040130000280 |
News Archive
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth of liver tissue in patients who have had parts of their liver removed surgically.
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments today announced it has received FDA 510(k) clearance of its new Clear + Brilliant laser aesthetic treatment, which will officially launch at the World Congress of Dermatology in Seoul, Korea on May 25, 2011.
› Verified 3 days ago
| Entity Name | Cullman Internal Medicine, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619920519 PECOS PAC ID: 2365354339 Enrollment ID: O20040719000987 |
News Archive
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth of liver tissue in patients who have had parts of their liver removed surgically.
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments today announced it has received FDA 510(k) clearance of its new Clear + Brilliant laser aesthetic treatment, which will officially launch at the World Congress of Dermatology in Seoul, Korea on May 25, 2011.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melinda Hart, MD 1890 Al Highway 157, Suite 300, Cullman, AL 35058-3601 Ph: (256) 737-8000 | Melinda Hart, MD 1890 Al Highway 157, Suite 300, Cullman, AL 35058-3601 Ph: (256) 737-8000 |
News Archive
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth of liver tissue in patients who have had parts of their liver removed surgically.
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments today announced it has received FDA 510(k) clearance of its new Clear + Brilliant laser aesthetic treatment, which will officially launch at the World Congress of Dermatology in Seoul, Korea on May 25, 2011.
› Verified 3 days ago
Joel T Johns, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2035 Al Highway 157, Cullman, AL 35058 Phone: 256-887-4996 Fax: 877-803-2404 | |
James Shu-lei Lee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2095 Fax: 256-737-2097 | |
Aesha Singh, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1930 Al Highway 157, Cullman, AL 35058 Phone: 256-735-5380 Fax: 256-417-4593 | |
Edward F. Mahan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2095 Fax: 256-737-2097 | |
Thomas B Oliver, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Main Ave Sw, Suite A, Cullman, AL 35055 Phone: 256-737-0880 | |
Dr. James R Matter, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 117 2nd Ave Se, Cullman, AL 35055 Phone: 256-739-4144 Fax: 256-739-0445 |